Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who received DAA therapy after HCC treatment. We retro...
Alternative Titles
Full title
Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2405841729
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2405841729
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0233212
